Laddar...
FDA Intensifies Drive to Reduce REMS Burdens: The Key Objective Is to Ease Workflow Obstacles for Pharmacists
The FDA is working to solve problems with the often-confusing risk evaluation and mitigation strategy program, which covers 74 pharmaceuticals and four drug classes. Issues include patient access to drugs and the dominant role of specialty pharmacies.
Sparad:
| I publikationen: | P T |
|---|---|
| Huvudupphovsman: | |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MediMedia USA, Inc.
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4745637/ https://ncbi.nlm.nih.gov/pubmed/26909000 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|